— Know what they know.
Not Investment Advice

300357.SZ SHZ

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
1W: +0.7% 1M: -9.1% 3M: -14.9% YTD: -26.9% 1Y: -22.1% 3Y: -40.1% 5Y: -65.3%
¥20.33 ($3.03)
+0.51 (+2.57%)
 
SHZ · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 37 · ¥10.6B mcap · 263M float · 4.21% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥10.6B ($1.6B)
52W Range18.65-35.84
Volume10,278,491
Avg Volume11,064,994
Beta0.37
Dividend¥0.25
Analyst Ratings
No analyst coverage
Company Info
CEOMushuang Hu
Employees1,808
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2014-01-21
No. 636, Zhiyuan North Road
Huzhou, ZH 313200
CN
86 57 2883 1088
About Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. operates as a biopharmaceutical enterprise, primarily engaged in the discovery, development, production, and sale of medicinal products. The company's core focus is on pharmaceuticals designed for the diagnosis and management of allergic conditions, which it supplies to both the Chinese domestic market and international clientele. Additionally, its portfolio encompasses various skincare lines and stem cell-related solutions. The firm's main offices are located in Huzhou, China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms